Small Cap Stocks Down Under 4 November 2022: Healthia (ASX:HLA)

Small Cap Stocks Down Under 4 November 2022: Healthia (ASX:HLA) 2
Healthia: An allied healthcare roll-up
The health industry on the ASX is saturated with healthcare companies trying to develop the next big drug or medical device. But today, we’re looking at Healthia (ASX:HLA) a company with a solid existing business. It is a rollup of allied healthcare businesses across several spaces, particularly podiatry and physiotherapy. The company is profitable and has a track record of growth since listing, but shares have taken a hit in the last 12 months as investors become wary of M&A-heavy companies.
Click here to read the previous edition of Small Cap Stocks Down Under published 28 October 2022. For in-depth research reports on ASX-listed stocks, check out our parent company, Pitt Street Research, or follow us on Facebook and Twitter.
Please register or upgrade your plan to access this content.

Save $$$
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$69
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar
30-Day Free Trial
$0
No Credit Card Required!
Get access to 5 publications per week
Weekly Investor Webinar
Profit Premium
$59
BILLED ANNUALLY
Get access to 5 publications per week
Access to the full research Archive
Weekly Investor Webinar